2005-001349-40: A Multicentre, Randomised, Assessor-Blind Study to Evaluate Efficacy and Safety of Daptomycin versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections (cSSTI) |
|
|
| | 3 | 130 | Europe | Daptomycin, Teicoplanin, Vancomycin hydrochloride, CB-109187, Cubicin, 350 mg powder for concentrate for solution for infusion, Targocid 400 mg, Vancomycin hydrochloride 500 mg, Cubicin, 350 mg powder for concentrate for solution for infusion, Targocid 400 mg, Vancomycin hydrochloride 500 mg | Novartis Pharma Services AG, Chiron Corporation Limited | Complicated Skin and Soft Tissue Infections (cSSTI) | | 05/08 | | |
2019-004884-32: COMPARAISON DU PROFIL PHARMACOCINETIQUE ET DE LA SECURITE DE LA DAPTOMYCINE ADMINISTREE PAR VOIE SOUS-CUTANEE PAR RAPPORT A LA VOIE INTRAVEINEUSE : ETUDE EN CROSS-OVER COMPARAISON DU PROFIL PHARMACOCINETIQUE ET DE LA SECURITE DE LA DAPTOMYCINE ADMINISTREE PAR VOIE SOUS-CUTANEE PAR RAPPORT A LA VOIE INTRAVEINEUSE : ETUDE EN CROSS-OVER |
|
|
| Not yet recruiting | 3 | 12 | Europe | DAPTOMYCINE, Powder for injection, DAPTOMYCINE | CHU CAEN Normandie, CHU CAEN Normandie | Volontaire sain Volontaire sain, Volontaire sain Volontaire sain, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
2021-003914-38: Different antimicrobial durations for the treatment of infections associated with OsteosynthesisMaterial implanted after long bone fractures DIFERENTES DURACIONES DE TRATAMIENTO ANTIMICROBIANO DE INFECCIONES ASOCIADAS AL MATERIAL DE OSTEOSÍNTESIS TRAS FRACTURA DE HUESO LARGO |
|
|
| Not yet recruiting | 3 | 378 | Europe | Ampicillim, amoxicillin/clavulanic, Cefazolin, Cefepime, Ceftazidime, CEFTRIAXONE, cloxacillin, daptomycin, Meropenem, Teicoplanin, Vancomycin, Amoxicillin, Amoxicillin / clavulanic acid, Ciprofloxacin, Levofloxacin, Linezolid, Moxifloxacin, Rifampicin, Powder and solvent for solution for infusion, Powder and solvent for solution for injection, Powder for solution for injection, Powder and solvent for suspension for injection, Powder for solution for injection/infusion, Tablet, , Capsule, Ampicillim, Amoxicillin/Clavulanic, Cefazolin, Cefepime, ceftazidime, CEFTRIAXONE, cloxacillin, daptomycin, Meropenem, Teicoplanin, Vancomycin, Amoxicillin, Amoxicillin / clavulanic acid, Ciprofloxacin, Clindamycin, Sulfametoxazol trimetoprim, Levofloxacin, Linezolid, Moxifloxacin, Rifampicin | Fundación Pública Andaluza para la Gestión de la Investigación, Instituto de Salud Carlos III. Ministerio de Ciencia e | Patients with long bone fractures who have had osteosynthesis material implanted to stabilize and assist fracturehealing and meet the criteria for Infections associated with osteosynthesis material Pacientes con fracturas de huesos largos a quienes se les ha implantado material de osteosíntesis para estabilizar y ayudar a la curación de la fractura y que cumplen con los criterios de Infecciones asociadas con el material de osteosíntesis., Patients with infections due to the implant used to stabilize a long bone fracture Pacientes con infecciones debidas al implante usado para estabilizar una fractura de hueso largo, Diseases [C] - Bacterial Infections and Mycoses [C01] | | | | |
